PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem
Topics & Concepts
MedicineProstate cancerSynthetic lethalityPARP inhibitorPoly ADP ribose polymeraseCancer researchOncologyCancerBioinformaticsDNA repairInternal medicinePolymeraseGeneBiologyGeneticsPARP inhibition in cancer therapyProstate Cancer Treatment and ResearchDNA Repair Mechanisms